Nineteen patients were analysed by fluorescence in situ hybridisation (FISH) with selected lIpl3 markers. They were examined because they had either isolated sporadic or familial aniridia, or aniridia with one or more of the WAGR (Wilms' tumour, aniridia, genital anomalies, and mental retardation) syndrome anomalies. The FISH markers from distal lIpl3 were cosmids F02121, PAX6 (aniridia), DllS324, and WT1 (Wilms' tumour predisposition). Two of the patients with isolated aniridia were abnormal, one with an apparently balanced reciprocal 7;11 translocation and an 1ipi3 breakpoint, which by FISH was shown to be -30 kb distal to the aniridia (PAX6) gene, and the other had a submicroscopic deletion involving part of PAX6 that extended distally for -245 kb. Two patients with aniridia together with other WAGR malformations had deletions involving all four cosmids. One case with aniridia associated with developmental and growth delay had a deletion including F02121 and PAX6 but not DI1S324 and WT1, while in a further case the deletion included all four test cosmids. These studies show that a combined conventional and molecular cytogenetic approach to patients presenting with aniridia is a useful method for differentiating between those with deletions extending into and including WT1 and therefore between those with high and low risks of developing Wilms' tumour.
Abstract
Nineteen patients were analysed by fluorescence in situ hybridisation (FISH) with selected lIpl3 markers. They were examined because they had either isolated sporadic or familial aniridia, or aniridia with one or more of the WAGR (Wilms' tumour, aniridia, genital anomalies, and mental retardation) syndrome anomalies. The FISH markers from distal lIpl3 were cosmids F02121, PAX6 (aniridia), DllS324, and WT1 (Wilms' tumour predisposition). Two of the patients with isolated aniridia were abnormal, one with an apparently balanced reciprocal 7;11 translocation and an 1ipi3 breakpoint, which by FISH was shown to be -30 kb distal to the aniridia (PAX6) gene, and the other had a submicroscopic deletion involving part of PAX6 that extended distally for -245 kb. Two patients with aniridia together with other WAGR malformations had deletions involving all four cosmids. One case with aniridia associated with developmental and growth delay had a deletion including F02121 and PAX6 but not DI1S324 and WT1, while in a further case the deletion included all four test cosmids. These studies show that a combined conventional and molecular cytogenetic approach to patients presenting with aniridia is a useful method for differentiating between those with deletions extending into and including WT1 and therefore between those with high and low risks of developing Wilms' tumour. The location of genes responsible for the clinical features of the WAGR syndrome (Wilms' tumour, aniridia, genitourinary abnormalities, and mental retardation) was first suggested by the association of cytogenetically visible interstitial deletions of the short arm of chromosome 11 involving band 1 lpl3'2 in patients presenting with one or more of the WAGR anomalies. Expression of these phenotypes, however, was noted to be variable even in patients with apparently identical deletions.' 3 From these early studies it was estimated that the overall risk for Wilms' tumour in sporadic and karyotypically normal In this study we have used FISH in combination with four cosmid probes including both the human aniridia (PAX6) and Wilms' tumour predisposition (WT1) loci. These probes have been cloned from an approximately 800 kb region of distal lip13. Our aim was to test whether FISH alone has the same sensitivity as other molecular methods for detecting and defining the extent of deletions, and hence their clinical significance, when applied to a series of patients presenting with isolated aniridia or aniridia with one or more features of the WAGR syndrome.
The study population Recruitment of patients was achieved principally by publicising the availability of a diagnostic FISH service using WAGR cosmids (see below) in the Bulletin of the Clinical Genetics Society of the United Kingdom. Nineteen patients, who fall into three principal phenotypic groups, have so far been studied (table 1). The first group comprised 13 patients with isolated sporadic or familial aniridia. The two patients in the second group presented with aniridia together with one or more of the WAGR syndrome abnormalities whereas the third group contained four patients with sporadic aniridia in combination with anomalies other than those normally associated with the WAGR syndrome. Ages ranged from 7 months to 7 years 4 months when referred for FISH studies. All had sporadic, isolated aniridia, normal karyotypes, and were not deleted for the four cosmids used.
CASE 1I1
He was referred at 5 years of age and was originally ascertained with isolated bilateral aniridia, glaucoma, and learning difficulties. He had a normal karyotype and was not deleted for the four FISH probes used. CASE 12 Recruited into the study at the age of 14 months, this male presented with aniridia, glaucoma, hypospadias, Fallot's tetralogy, hypoplastic first left rib, and absent first right rib. This male was the third child born after an uneventful pregnancy at 36 weeks with a birth weight of 2300 g and at birth was noted to have undescended testes and mild hypospadias. However, following conventional cytogenetic studies which showed an interstitial lipi 3-p14.2 deletion, examination by a paediatric ophthalmologist found that he had bilateral aniridia. At 3 months, ultrasound examination showed that he only had one kidney (the left).
At that time his left testis was palpable in the scrotum and there was no evidence of Wilms' tumour. At 9 months he was progressing well and was functioning at the bottom of the normal range. At that time he was also noted to have mild bilateral microphthalmia, deep set eyes, bilateral low set ears with rather overfolded helices, but still no evidence of Wilms' tumour. FISH studies with the WAGR cosmids showed that all four loci defined by the probes used were deleted in the abnormal chromosome 11. The parental karyotypes were both normal.
CASE 1 5 A female was noted shortly after birth to have bilateral aniridia and has subsequently developed glaucoma. A renal scan at 3 months of age was normal, and physical examination at 5 months showed a rather unhappy child with a head circumference on the 50th centile and length on the 25th centile. This was a familial isolated aniridia family with affected subjects in three generations. Conventional and molecular cytogenetic results were both normal. CASE 19 This was a familial isolated aniridia family with transmission from mother to daughter. Chromosomes in both patients were apparently normal, but FISH studies showed a partial deletion of FAT5 (PAX6) ( fig 2D) and absence of the F02121, C 1 170, and 3UT5 cosmids on one chromosome 1 1 indicating that the deletion extends approximately 245 kb distal from FAT5.
Discussion
The aim at the outset of this study was to determine the frequency of molecular cytogenetic deletions involving loci within the WAGR region in a series of patients ascertained with isolated sporadic or familial aniridia. However, additional patients were also studied either because they had aniridia in association with WAGR syndrome or other malformations, or cytogenetically visible interstitial 1 Ip deletions in which FISH studies were used to define the extent and hence significance of the deletion within the WAGR region. The 19 patients are considered by phenotypic group. The first contained 13 patients with isolated sporadic or familial aniridia, and using a combination of both conventional and molecular cytogenetic techniques, two cases (one sporadic and one familial) were found to be abnormal. The first, case 1, has an apparently balanced t(7; 11) and in our previous report16 we suggested that this patient's aniridia was the result of a position effect caused by the translocation breakpoint disrupting the chromatin domain distal to PAX6. Such an effect had been reported in patients SIMO and SGL by The second patient, case 19, part of a familial aniridia pedigree, was found to have a submicroscopic deletion involving the distal part of the FAT5 cosmid ( fig 2D) and extending distally for -245 kb. Further studies are in progress to determine whether PAX6 has been disrupted by this deletion. However, this result offers clinical reassurance by showing that the deletion does not extend proximally to WT1, and is similar to a previously reported case of familial aniridia.14 By contrast, a familial aniridia family with a deletion including PAX6 and WT1 was associated with isolated aniridia in the mother, but the identical deletion in her son produced aniridia, a horseshoe kidney, and Wilms' tumour."
We detected one familial submicroscopic deletion among the 13 (7.7%) cases of isolated aniridia (10 sporadic, three familial). Previous reports using either PFGE in combination with FISH,"2-4 or quantitative Southern hybridisation combined with conventional cytogenetics,"' have identified seven deletions out of 42 patients who at the time of analysis were described as having isolated aniridia. Three of these deletions were cytogenetically visible and in each case the molecular studies confirmed the involvement of WT1. The remaining four deletions were submicroscopic, one of which included WT1V.2 All four of these reported submicroscopic deletions included the region covered by the cosmids used in this study and so would have been detected by our methods. Our lower detection rate for deletions among isolated aniridia patients probably reflects the ascertainment bias of the different studies, but if we combine these data, deletions have been detected in a total of eight out of 59 (13.5%) isolated aniridia patients, five sporadic and three familial. As mentioned above, there have also been three reported cases of isolated aniridia (two familial and case 1) with apparent position effect breakpoints distal to and not including PAX6.'5 16 Overall, therefore, 1 1 out of 59 (18.6%) of isolated aniridia cases have been reported with abnormalities which have been identified and characterised using molecular methods.
The second group consists of two patients with aniridia associated with one or more of the WAGR syndrome abnormalities, who were shown to be deleted at all four loci. The deletion in one (case 14) was cytogenetically visible but was submicroscopic in the other (case 16). Case 14 has developmental delay and genitourinary and renal anomalies in addition to his aniridia and, as he is deleted for all four cosmids, must be considered at high risk of developing renal tumours before the age of 7.18 Case 16 underlines the importance of screening all aniridia patients as early as possible. He presented with sporadic aniridia and mild genital anomalies and Wilms' tumour was subsequently discovered during a regular three monthly renal ultrasound examination. The tumour was successfully treated after which FISH studies showed that he had a submicroscopic deletion which included all four cosmids. He has no other significant clinical problems at the age of 51/2 years. The genitourinary (GU) anomalies observed in these two males are not surprising as 30-50% of males with WAGR deletions have GU anomalies, including cryptorchidism and hypospadias, whereas GU anomalies in equivalent female patients are rarely observed.
The four patients comprising the third group all had aniridia but with clinical features other than those of the WAGR syndrome. Cases 11 and 12 did not have deletions detectable with the cosmids used, but the possibility of a smaller deletion, particularly in PAX6, cannot be excluded by our test. Further molecular screening of these patients will be required to determine whether their aniridia is the result of an intragenic PAX6 mutation, and until these results are known we cannot be sure whether their other malformations are coincidental to their aniridia. In contrast to cases 11 and 12, case 13 had a visible 1 I p I 3p 1 were shown to be deleted for all the WAGR loci tested in this study,'7 whereas the l 1 p3 breakpoint in another case (DG85)'3 did not involve WT1.
These combined results illustrate the resolving power of a variety of molecular techniques for defining the extent of WAGR region deletions in patients presenting with either isolated aniridia or in association with other WAGR anomalies. Our results using FISH together with prudently selected probes show that this approach is sufficient to identify and define the extent of both visible and submicroscopic deletions, thereby providing clinical geneticists with essential prognostic information with respect to the risk of Wilms' tumour onset. Clearly, high resolution molecular techniques such as PFGE are still essential for the detailed refinement of deletion breakpoints, but as successful treatment for Wilms' tumour is strongly correlated with early diagnosis, it is clear that the results presented in this and previous reports indicate that rapid FISH studies should be performed on all aniridia patients as soon after diagnosis as is practicable.
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